Jonathan Cohen Sabban

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

SPARK Venture Management Ltd. (SPARK Ventures) is a venture capital subsidiary of Querist Ltd. founded in 1989 by Kiko Duffy and Thomas Alfred Teichman. The firm is headquartered in London, United Kingdom.

RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany.

Part of University of Aberdeen, The Rowett Research Institute engages in conducting research to help in solving nutritional problems. The company is based in Aberdeen, UK. Founded in 1962.

Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark.

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark.

American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany.

PharmaSwiss SA engages in the provision of healthcare solutions. It also offers consulting services. The company was founded on January 24, 2000 and is headquartered in Zug, Switzerland.

SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany.

CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK.

Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland.

Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer.

Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages.

Hi Inov SAS (Hi Inov) is the venture capital arm of Dentressangle Initiatives SAS. The firm was founded by Pierre-Henri Dentressangle and Valérie Gombart in 2012. It is headquartered in Paris, France with an additional office in Bavaria, Germany.

Mint Solutions Holding BV develops solutions that facilitates medical institutions to control medication. It is a complete closed loop medication safety suite for hospitals and healthcare institutions. The company was founded by Ívar Helgason and Gauti Reynisson in 2009 and is headquartered in Washington, the Netherlands.

interCloud SAS is a holding company, which develops software solutions. It offers service oriented platform for cloud applications and managed solutions. The company was founded by Jérôme Dilovya, Antoine Valat, and Benjamin Ryzman in 2010 and is headquartered in Paris, France.

TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.

Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

DayTwo Ltd. engages in the provision of glycemic control solution. It focuses on personalized nutrition and actionable insights that allow patient to live healthier, and maintain target blood glucose levels. It offers solutions for employers, clinicians, and patients. The company was founded by Marius Nacht, Yuval Ofek, Lihi Segal, and Yair Schindel in 2015 and is headquartered in Adanim, Israel.

Dermala, Inc. develops treatments for the chronic skin diseases. It focuses on the most prevalent skin diseases like acne and eczema and skin conditions like skin aging. The firm is developing end-to-end solutions that will consist of microbiome analysis, personalized topical and oral treatments and an app for tracking the treatment outcome and treatment optimization via data analytics, machine learning and AI. The company was founded by Lada Rasochova in 2014 and is headquartered in San Diego, CA.

Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA.

LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France.

Ganymed Robotics SAS develops robots for orthopaedic surgeries. The company was founded by Sophie Cahen in June 26, 2018 and is headquartered in Paris, France.

BSN medical GmbH develops and markets wound care and related vascular diseases, lymphology and non-invasive orthopedic products. The firm specializes in the supply and manufacture of medical accessories for wound care, compression therapy, orthopedics, fracture management, physiotherapy and bandage applications. It markets products under brands, such as Leukoplast, Leukomed, Gypsona, Orthoglass, JOBSt, Radiante, Delta-cast, Actimove and Tridocur. Its focus areas encompass product innovation, brand development and hands-on training and workshops. The company was founded in April 2001 and is headquartered in Hamburg, Germany.